72 a risperdal imprint
Researchers from the School of Life Course Sciences and Biomedical Engineering & Imaging Sciences alongside a group of international experts have undertaken the most comprehensive meta-analysis to date on treatments and other factors associated with NMDAR antibody encephalitis outcome, published this week in JAMA Neurology. NMDAR antibody encephalitis is a disease that predominately affects children and young adults. The disease […]
Continue reading »